Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for cancer, has appointed Anne E. Borgman, M.D., as Chief Medical Officer. Borgman is an accomplished Chief Medical Officer, business executive, scientific advisor and board director with more than 20 years of experience devising and executing clinical development strategies that have led to multiple oncology drug approvals. “Dr. Borgman joins Circle with an establish...